(NASDAQ: NTRB) Nutriband's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 4.81%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.48%.
Nutriband's earnings in 2025 is -$32,082,447.On average, 1 Wall Street analyst forecast NTRB's earnings for 2026 to be -$74,616,275, with the lowest NTRB earnings forecast at -$74,616,275, and the highest NTRB earnings forecast at -$74,616,275.
In 2027, NTRB is forecast to generate $17,450,580 in earnings, with the lowest earnings forecast at $17,450,580 and the highest earnings forecast at $17,450,580.